George Karp
Impact in
-
- Cancer Risks and Factors
- Lung Cancer Research Studies
-
- Platelet Disorders and Treatments
Papers in
-
- Neuroendocrine Tumor Research Advances 2
- Co-authors
- Sun‐Whe Kim (1 shared paper)Srinivasan Rajaraman (1 shared paper)B. Haber (1 shared paper)Jin Ishizuka (1 shared paper)Courtney M. Townsend (1 shared paper)George H. Greeley (1 shared paper)R. Daniel Beauchamp (1 shared paper)J. C. Thompson (1 shared paper)
- Journals
- Thrombosis and Haemostasis (2 papers)American Journal of Hematology (2 papers)The Journal of Pediatrics (1 paper)Journal of Endodontics (1 paper)Archives of Biochemistry and Biophysics (1 paper)
- Partner nations
- United StatesSouth AfricaCanada
In The Last Decade
George Karp
16 papers receiving 289 citations
Peers
Comparison fields: 5 of 59
- Oncology 98
- Hematology 36
- Rheumatology 42
- Neurology 40
- Genetics 27
Countries citing papers authored by George Karp
This map shows the geographic impact of George Karp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Karp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Karp more than expected).
Fields of papers citing papers by George Karp
This network shows the impact of papers produced by George Karp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Karp. The network helps show where George Karp may publish in the future.
Co-authors
The 25 scholars most cited alongside George Karp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 110 | |
| 2 | 2008 | 45 | |
| 3 | 1997 | 42 | |
| 4 | 1984 | 19 | |
| 5 | 1988 | 16 | |
| 6 | 1989 | 14 | |
| 7 | Phase II trial of etoposide in previously treated small cell carcinoma of the lung. | 1984 | 12 |
| 8 | 1991 | 9 | |
| 9 | 1992 | 9 | |
| 10 | 1987 | 8 | |
| 11 | 1987 | 6 | |
| 12 | 1992 | 4 | |
| 13 | VP-16-213. A phase II trial using a weekly schedule. | 1981 | 3 |
| 14 | 1984 | 2 | |
| 15 | 1988 | 1 | |
| 16 | 1990 | 1 |
About George Karp
George Karp is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Oncology, Molecular Biology and Genetics, having authored 16 papers that have together received 301 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Lung Cancer Research Studies (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Folate and B Vitamins Research (1 paper), Head and Neck Cancer Studies (1 paper) and Hemophilia Treatment and Research (1 paper). The work is most often cited by research in Oncology (98 citations), Hematology (36 citations), Rheumatology (42 citations), Neurology (40 citations) and Genetics (27 citations). George Karp has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Sun‐Whe Kim, Srinivasan Rajaraman, B. Haber, Jin Ishizuka, Courtney M. Townsend, George H. Greeley, R. Daniel Beauchamp, J. C. Thompson, Dilipkumar Parekh and I. David Goldman. Their work appears in journals such as Thrombosis and Haemostasis, American Journal of Hematology, The Journal of Pediatrics, Journal of Endodontics and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.